Androgens promote T cell exhaustion in tumor-infiltrating CD8+ T cells by suppressing effector molecule production via AR signaling, exacerbating male-biased progression in malignancies such as bladder, colorectal, hepatocellular, and cutaneous cancers (45, 48–52). Here, AR is linked to neoplasm.